(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7.68%186.27B | -0.59%131.68B | -5.49%86.73B | -0.54%44.28B | -0.50%172.99B | 4.67%132.47B | 8.20%91.77B | 11.55%44.52B | 53.89%173.86B | 57.59%126.56B |
Operating income | 7.68%186.27B | -0.59%131.68B | -5.49%86.73B | -0.54%44.28B | -0.50%172.99B | 4.67%132.47B | 8.20%91.77B | 11.55%44.52B | 53.89%173.86B | 57.59%126.56B |
Operating expenses | -7.16%-168.16B | -2.75%-122.43B | -3.37%-83B | -13.69%-42.49B | 0.39%-156.93B | -3.74%-119.16B | -5.92%-80.3B | -4.68%-37.37B | -50.70%-157.54B | -52.70%-114.87B |
Gross profit | 12.74%18.11B | -30.49%9.25B | -67.54%3.72B | -74.94%1.79B | -1.58%16.06B | 13.85%13.31B | 27.41%11.47B | 69.75%7.15B | 93.29%16.32B | 130.07%11.69B |
Selling expenses | -59.94%-155.42M | -45.66%-124.73M | 4.24%-58.01M | 24.93%-18.72M | -8.27%-97.17M | -46.14%-85.63M | -61.89%-60.57M | -23.18%-24.94M | -22.18%-89.75M | -5.00%-58.6M |
Administrative expenses | -33.27%-2.39B | -22.73%-1.84B | -46.27%-1.21B | -10.03%-513.23M | -15.09%-1.79B | -45.66%-1.5B | -20.85%-827.43M | -27.35%-466.44M | -16.97%-1.56B | -5.56%-1.03B |
Research and development expenses | 15.83%-327.09M | 30.50%-220.17M | 56.64%-107.69M | 72.52%-36.14M | -42.67%-388.61M | -183.29%-316.79M | -285.84%-248.34M | -544.57%-131.49M | -56.92%-272.38M | -6.13%-111.82M |
Profit from asset sales | -90.27%2.83M | -42.10%9.31M | -38.78%8.15M | 148.86%32.43M | 652.23%29.13M | 1,042.27%16.07M | 5,423.45%13.31M | 25,482.23%13.03M | -549.05%-5.27M | -132.89%-1.71M |
Revaluation surplus | 204.33%1.68B | 651.01%1.79B | 211.98%1.26B | 94.03%-170.22M | 52.17%-1.61B | 87.14%-325.38M | 60.42%-1.13B | -97.64%-2.85B | -75.78%-3.37B | -155.44%-2.53B |
-Changes in the fair value of other assets | 204.33%1.68B | 651.01%1.79B | 211.98%1.26B | 94.03%-170.22M | 52.17%-1.61B | 87.14%-325.38M | 60.42%-1.13B | -97.64%-2.85B | -75.78%-3.37B | -155.44%-2.53B |
Impairment and provision | -69.90%-144.33M | -118.24%-60.53M | -10.23%-29.8M | 72.65%-5.38M | -40.24%-84.95M | 33.41%-27.73M | 29.87%-27.03M | -163.01%-19.68M | 74.23%-60.58M | -458.02%-41.65M |
-Other impairment is provision | -69.90%-144.33M | -118.24%-60.53M | -10.23%-29.8M | 72.65%-5.38M | -40.24%-84.95M | 33.41%-27.73M | 29.87%-27.03M | -163.01%-19.68M | 74.23%-60.58M | -458.02%-41.65M |
Special items of operating profit | 219.92%2.6B | -54.88%308.27M | -22.72%290.22M | 42.41%211.67M | 381.44%811.27M | 220.45%683.23M | 212.39%375.53M | 710.74%148.63M | -62.30%168.51M | 17.06%213.21M |
Operating profit | 39.28%16.29B | -32.98%7.14B | -65.21%3.02B | -68.46%1.08B | 18.35%11.7B | 45.89%10.65B | 76.57%8.68B | 60.84%3.42B | 131.44%9.88B | 193.76%7.3B |
Financing cost | -66.10%-3B | -70.58%-2.04B | -87.81%-1.37B | -313.76%-643.05M | -65.15%-1.81B | -30.06%-1.2B | -31.41%-729.52M | 35.20%-155.42M | 17.25%-1.1B | 8.35%-919.08M |
Special items of earning before tax | 5.41%-80.01M | -15.93%-63.33M | 40.56%-22.42M | 85.25%-5.28M | -153.57%-84.59M | -690.92%-54.63M | -7,164.27%-37.73M | -782,681.05%-35.83M | 53.05%-33.36M | -59.26%-6.91M |
Earning before tax | 34.71%13.21B | -46.43%5.04B | -79.44%1.63B | -86.66%431.19M | 11.98%9.8B | 47.48%9.4B | 81.47%7.91B | 71.15%3.23B | 204.40%8.76B | 331.30%6.37B |
Tax | -79.02%-4.68B | 13.00%-2.76B | 67.30%-1.01B | 88.26%-158.21M | 21.48%-2.61B | -47.13%-3.18B | -102.67%-3.09B | -103.12%-1.35B | -736.84%-3.33B | -1,039.67%-2.16B |
After-tax profit from continuing operations | -4.63%6.76B | -63.48%2.27B | -87.23%615.2M | -85.51%272.98M | 30.53%7.08B | 47.65%6.23B | 70.05%4.82B | 53.83%1.88B | 118.98%5.43B | 146.92%4.22B |
After-tax profit from non-continuing business | 1,557.01%1.77B | ---- | ---- | ---- | --107.08M | ---- | ---- | ---- | ---- | ---- |
Earning after tax | 18.62%8.53B | -63.48%2.27B | -87.23%615.2M | -85.51%272.98M | 32.50%7.19B | 47.65%6.23B | 70.05%4.82B | 53.83%1.88B | 118.98%5.43B | 146.92%4.22B |
Minority profit | -75.02%280.91M | -118.39%-169.2M | -113.12%-87.95M | -147.96%-44.15M | 249.74%1.12B | 39.71%919.87M | 57.80%670.14M | -57.65%92.04M | 114.61%321.6M | 570.80%658.39M |
Profit attributable to shareholders | 35.98%8.25B | -53.96%2.44B | -83.05%703.14M | -82.30%317.12M | 18.82%6.07B | 49.12%5.31B | 72.21%4.15B | 77.88%1.79B | 119.26%5.11B | 121.07%3.56B |
Basic earnings per share | 35.71%0.38 | -54.03%0.114 | -82.90%0.033 | -82.14%0.015 | 16.67%0.28 | 50.30%0.248 | 72.32%0.193 | 78.72%0.084 | 118.18%0.24 | 120.00%0.165 |
Diluted earnings per share | 35.71%0.38 | -54.03%0.114 | -82.90%0.033 | -81.93%0.015 | 16.67%0.28 | 50.30%0.248 | 72.32%0.193 | 0.083 | 0.24 | 0.165 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data